| Goods and Services | Pharmaceuticals, pharmaceutical drugs and pharmaceutical preparations for immunization and/or for the prevention or treatment of diseases and conditions affecting various body systems, namely,respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, teeth diseases and decay, bone metabolic disorders, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; dermatological pharmaceutical products; pharmaceutical preparations for use in dermatology; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, primary ciliary dyskinesia, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, bone metabolic disorders, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; tissue-regenerative pharmaceutical preparations for the treatment of respiratory diseases and disorders, dermatological diseases and disorders, musculoskeletal and orthopedic diseases and disorders, diabetes, dental and periodontal diseases and disorders, cardiovascular and neurological diseases and disorders, muscular and joint pain, ophthalmic diseases and disorders, gynecological and obstetric diseases and disorders, and organ repair and regeneration, in the nature of liver regeneration, kidney regeneration, and intestinal tissue repair; tissue-regenerative pharmaceutical preparations for the treatment of rare diseases involving tissue degeneration or defects, such as epidermolysis bullosa, osteogenesis imperfecta, and amyotrophic lateral sclerosis (ALS); cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhalant anaesthetic preparations; inhalers for medical purposes, sold filled with pharmaceutical preparations for treating respiratory diseases and disorders; medicated dental preparations for regeneration of teeth, periodontal tissues, dental pulp, and treatment of alveolar bone loss; dental articles, namely materials for tooth restoration, dental cements, materials for dental fillings, bone fillers consisting of living materials as well as bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compounds, namely, pharmaceutical preparations for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for treatment and prevention of immune system and autoimmune system related diseases and disorders; pharmaceuticals and medical preparations comprising nucleic acids for the immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, bone metabolic disorders, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; pharmaceuticals (MRNA) for the treatment of lung diseases; pharmaceuticals for the treatment of congenital diseases, in particular lung congenital diseases and/or autoimmune diseases; chemicals used for delivering nucleic acids to cells, in particular lipids for the delivery of nucleic acids for medical use; chemicals used for stabilizing nucleic acid delivery systems, in particular for stabilizing lipid nanoparticles for medical use; pharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics for medical use; pharmaceutical preparations comprised of nucleic acids, namely, messenger RNA, and lipid nanoparticles for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, bone metabolic disorders, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; pharmaceutical preparations comprised of lipid nanoparticles for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, bone metabolic disorders, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; autoantigens, namely, pharmaceutical preparations for the treatment and prevention of human autoimmune diseases and cancer; vaccines; vaccine preparations; vaccine adjuvants; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; antiviral drugs for treating influenza; vaccines for human use; pharmaceutical preparations in the nature of fat emulsions composed of nucleic acids and/or nanocarriers, namely, intravenous lipid emulsions for use with medical infusions; aerosols formulations and spray formulations for medical use , namely, mRNA delivery, vaccination and treatment of respiratory system diseases; aerosols formulations and spray formulations for medical use, namely, inhaled mRNA drugs; aerosols formulations and spray formulations for medical use, namely, inhaled vaccines; aerosols formulations and spray formulations for medical use, namely, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Medicinal healthcare preparations namely preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations, aerosols formulations, spray formulations; medicinal preparations and substances for treating diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, teeth diseases and decay, bone metabolic disorders, bone fracture, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; Medicinal infusions for treating diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, bone metabolic disorders, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; serotherapeutic medicines for passive immunity, modulating immune responses, convalescent plasma therapies, treating autoimmune diseases, inflammatory conditions, cancer, viral infections, and preventing or treating allergic reactions; antiallergic medicines; nucleic acid sequences for medical purposes; biological preparations, namely, nucleic acid sequences for medical purposes; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of injectables that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of parenteral formulations that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of oral liquids that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of powders, tablets, and capsules that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of lyophilized compositions that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of dry-powder formulations for airway delivery that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of nasal sprays that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of nebulized solutions that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of aerosols that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of topical formulations that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents in the form of transdermal patches that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; transdermal patches featuring lipid nanoparticle substances and lipid nanoparticle preparations for medical purposes, namely, drug delivery agents that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of injectables that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of parenteral formulations that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of oral liquids that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of powders, tablets, and capsules that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of lyophilized compositions that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of dry-powder formulations for airway delivery that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of nasal sprays that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of nebulized solutions that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of aerosols that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of topical formulations that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of transdermal patches that facilitate delivery of nucleic acids; transdermal patches featuring lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes that facilitate delivery of nucleic acids; lipid nanoparticle materials in the nature of intravenous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of intramuscular lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of subcutaneous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of oral lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of inhaled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of instilled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of intravenous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of intramuscular lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of subcutaneous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of oral lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of inhaled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of instilled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle preparations for medicines, for stabilizing of chemical, biochemical, biological and pharmaceutical substances; acids for pharmaceutical purposes, namely nucleic acids, recombinant nucleic acids, fatty acid esters, phospholipids, Ionizable Lipids, cholesterol derivative acids; adjuvants for medical purposes; cellular function activating agents for medical purposes; chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, namely, respiratory system diseases, lung diseases, airway diseases, nasal diseases, lung viral diseases, lung ciliopathies, lung autoimmune diseases, pathogen infections, viral infections, bacterial infections, fungal infections, parasitic infections, pathogen-caused diseases, respiratory system diseases, viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, neurodegenerative diseases, neuroinflammatory diseases, neuropathies, circulatory system diseases, cardiovascular diseases, blood disorders, vascular diseases, digestive system diseases, gastrointestinal diseases, liver diseases, pancreatic diseases, urinary system diseases, kidney diseases, bladder disorders, urinary tract infections, reproductive system diseases, infertility, hormonal disorders, reproductive tract infections, muscular diseases, muscular dystrophies, myopathies, inflammatory muscle diseases, tendon diseases, bone diseases, osteoporosis, osteoarthritis, teeth diseases and decay, bone metabolic disorders, bone fracture, skin diseases, dermatological conditions, inflammatory skin diseases, skin infections, endocrine system diseases, diabetes, thyroid disorders, adrenal gland disorders, metabolic diseases, genetic metabolic disorders, acquired metabolic syndromes, lymphatic system diseases, lymphedema, lymphatic infections, psychiatric conditions, mental health conditions, mood disorders, anxiety disorders, psychotic disorders, ocular diseases, glaucoma, macular degeneration, ocular infections, ear, nose and throat (ENT) diseases, rhinitis, sinusitis, otitis, throat infections, hematologic diseases, anemia, hemophilia, clotting disorders, hair restoration, and for pain management for chronic or terminal illnesses; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; compounds being pharmaceutical preparations for treating cancer; all of the aforementioned goods not for veterinary use. |
